(Q36170672)

English

Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

author name string

Fred Y Aoki

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Canadian Journal of Infectious Diseases & Medical Microbiology

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

17-27

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

copyright license

Creative Commons Attribution 4.0 International

1 January 2003

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Successful treatment of herpes labialis with topical acyclovir.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Pharmacokinetics of acyclovir after intravenous and oral administration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Genital herpes simplex virus infections: clinical manifestations, course, and complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Mechanism of action and selectivity of acyclovir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Efficacy of combined treatment with oral and topical acyclovir in first episode genital herpes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Pharmacokinetics of acyclovir suspension in infants and children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Prophylactic oral acyclovir in outbreaks of primary herpes simplex virus type 1 infection in a closed community

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

1 October 2017

Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

A Trial of Topical Acyclovir in Genital Herpes Simplex Virus Infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Double-blind Placebo-Controlled Trial of Oral Acyclovir in First-Episode Genital Herpes Simplex Virus Infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Oral acyclovir in the suppression of recurrent non-genital herpes simplex virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Human gastrointestinal absorption of acyclovir from tablet duodenal infusion and sipped solution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Prophylaxis against herpes labialis with acyclovir cream--a placebo-controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Oral Acyclovir for Treatment of First-Episode Herpes Simplex Virus Proctitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Recurrent genital herpes and suppressive oral acyclovir therapy. Relation between clinical outcome and in-vitro drug sensitivity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

One-year suppression of frequent recurrences of genital herpes with oral acyclovir.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Treatment of recurrent herpes simplex labialis with oral acyclovir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

2 July 2018

Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

Recurrent erythema multiforme: clinical features and treatment in a large series of patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

Chronic suppression for six months compared with intermittent lesional therapy of recurrent genital herpes using oral acyclovir: effects on lesions and nonlesional prodromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094903

23 September 2018

Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral acyclovir suppressive therapy in severe recurrent genital herpes. A double-blind, placebo-controlled cross-over study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preventive therapy of herpes labialis associated with trigeminal surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic oral acyclovir in recurrent genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of eczema herpeticum with oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acyclovir in late pregnancy to prevent neonatal herpes simplex

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical acyclovir in the management of recurrent herpes labialis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of recurrent genital herpes by single daily dosages of acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of recurrent genital herpes simplex infections with oral acyclovir

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acyclovir Prevents Reactivation of Herpes Simplex Labialis in Skiers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic and pharmacokinetic studies following oral administration of 14C-famciclovir to healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent genital herpes suppressed by oral acyclovir: a multicentre double blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term oral acyclovir treatment prevents recurrent genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled, crossover study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral acyclovir for episodic treatment of recurrent genital herpes. Efficacy and safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/18159421

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2003/984698

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36170672&oldid=1992434169"